The manufacturer was informed that on (b)(6) 2023, after sizing with corcym sizer, optiform mitral valve size 27 was implanted.Reportedly, the leaflet was stuck and difficult to open / close.As such, another optiform valve size 27 was implanted in the patient.Based on the further inforamtion received, while testing the leaflet with a tester after the suturing was completed, the blockage was detected.As reported, there was no abnormal geometry in patient's anatomy and no concomitant procedure was performed.Furthermore, no additional debridement or annular restructuring was performed prior to the second implant.Reportedly, 30 minutes was added to the procedure as a result of this event, and patient was stable through the prolongation of surgery with a good outcome.
|
A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.Since the device was discarded at the hospital and was not returned to the manufacturer, further investigation on the device cannot be performed and definitive root cause of the reported event cannot be established.However, from the document review performed, no manufacturing deficiencies were noted.Should further information be received in the future, a follow up report will be provided.H3 other text : the valve was scrapped by site due to contamination.
|